Payment overview · 2025
General Payments
$207.75
10 reported records · 6 companies
Healthcare provider profile · identity verified
Solomon Tafari, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · DECATUR, GA · NPI 1235128828
Verified facts
What the public records show
CMS Open Payments records show Solomon Tafari, M.D. received $207.75 in general payments during 2025 across 10 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 37.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $77.53 | 37.3% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $42.36 | 20.4% | 2 | 2025 |
| Echosens North America, Inc. | Unresolved — no canonical attribution shown | $25.07 | 12.1% | 2 | 2025 |
| ViiV Healthcare Company | Unresolved — no canonical attribution shown | $24.82 | 11.9% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $21.18 | 10.2% | 1 | 2025 |
| Actelion Pharmaceuticals US, Inc. | Unresolved — no canonical attribution shown | $16.79 | 8.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $207.75 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $77.53 | 3 | 2025 |
Source payment records
|
|||||
| Fibroscan Normalized: fibroscan |
Device | Echosens North America, Inc. | $25.07 | 2 | 2025 |
Source payment records
|
|||||
| APRETUDE Normalized: apretude |
Drug | ViiV Healthcare Company | $24.82 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $22.17 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $21.18 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $20.19 | 1 | 2025 |
Source payment records
|
|||||
| OPSUMIT Normalized: opsumit |
Drug | Actelion Pharmaceuticals US, Inc. | $16.79 | 1 | 2025 |
Source payment records
|
|||||
| UPTRAVI Normalized: uptravi |
Drug | Actelion Pharmaceuticals US, Inc. | $16.79 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1406 | 167 |
| Amlodipine Besylate | Amlodipine Besylate | 1274 | 137 |
| Memantine Hcl | Memantine Hcl | 908 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 904 | 63 |
| Gabapentin | Gabapentin | 862 | 95 |
| Eliquis | Apixaban | 805 | 74 |
| Omeprazole | Omeprazole | 670 | 82 |
| Levothyroxine Sodium | Levothyroxine Sodium | 614 | 59 |
| Famotidine | Famotidine | 612 | 40 |
| Sertraline Hcl | Sertraline Hcl | 607 | 42 |
| Furosemide | Furosemide | 604 | 70 |
| Hydralazine Hcl | Hydralazine Hcl | 566 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 551 | 65 |
| Trazodone Hcl | Trazodone Hcl | 524 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 504 | 46 |
| Carvedilol | Carvedilol | 501 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 492 | 64 |
| Donepezil Hcl | Donepezil Hcl | 491 | 33 |
| Mirtazapine | Mirtazapine | 468 | 33 |
| Valsartan | Valsartan | 432 | 34 |
| Levetiracetam | Levetiracetam | 385 | 30 |
| Metoprolol Succinate | Metoprolol Succinate | 369 | 41 |
| Nifedipine Er | Nifedipine | 363 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 354 | 39 |
| Lisinopril | Lisinopril | 344 | 38 |
| Risperidone | Risperidone | 332 | 11 |
| Montelukast Sodium | Montelukast Sodium | 290 | 22 |
| Allopurinol | Allopurinol | 270 | 23 |
| Jardiance | Empagliflozin | 261 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 257 | 21 |
| Spironolactone | Spironolactone | 238 | 19 |
| Potassium Chloride | Potassium Chloride | 235 | 45 |
| Losartan Potassium | Losartan Potassium | 233 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 227 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 204 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 188 | 14 |
| Tramadol Hcl | Tramadol Hcl | 188 | 49 |
| Xarelto | Rivaroxaban | 186 | 14 |
| Metformin Hcl | Metformin Hcl | 173 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 165 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 164 | 17 |
| Baclofen | Baclofen | 159 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 157 | 16 |
| Bupropion Xl | Bupropion Hcl | 154 | suppressed |
| Torsemide | Torsemide | 152 | 17 |
| Aripiprazole | Aripiprazole | 136 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 123 | 12 |
| Sevelamer Carbonate | Sevelamer Carbonate | 119 | 14 |
| Buspirone Hcl | Buspirone Hcl | 114 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 107 | 18 |
| Midodrine Hcl | Midodrine Hcl | 104 | 26 |
| Benztropine Mesylate | Benztropine Mesylate | 97 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 96 | 12 |
| Entresto | Sacubitril/Valsartan | 92 | suppressed |
| Lamotrigine | Lamotrigine | 88 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 87 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 86 | 11 |
| Pregabalin | Pregabalin | 86 | 16 |
| Metformin Hcl Er | Metformin Hcl | 85 | suppressed |
| Glipizide | Glipizide | 83 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 83 | 13 |
| Calcitriol | Calcitriol | 80 | suppressed |
| Olanzapine | Olanzapine | 77 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 77 | suppressed |
| Finasteride | Finasteride | 76 | 13 |
| Latanoprost | Latanoprost | 73 | 26 |
| Rivastigmine | Rivastigmine Tartrate | 71 | suppressed |
| Sucralfate | Sucralfate | 71 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 22 |
| Flecainide Acetate | Flecainide Acetate | 67 | suppressed |
| Prednisone | Prednisone | 66 | 24 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 63 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 31 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | suppressed |
| Bumetanide | Bumetanide | 60 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 59 | suppressed |
| Myrbetriq | Mirabegron | 58 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 41 |
| Ezetimibe | Ezetimibe | 56 | 12 |
| Simvastatin | Simvastatin | 56 | suppressed |
| Letrozole | Letrozole | 55 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 55 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | suppressed |
| Minoxidil | Minoxidil | 52 | suppressed |
| Verapamil Er | Verapamil Hcl | 52 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 49 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 49 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 48 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 47 | 40 |
| Levemir Flexpen | Insulin Detemir | 47 | suppressed |
| Meloxicam | Meloxicam | 47 | 12 |
| Ranolazine Er | Ranolazine | 47 | suppressed |
| Estradiol | Estradiol | 45 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 44 | 27 |
| Lorazepam | Lorazepam | 43 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 35 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 42 | suppressed |
| Alprazolam | Alprazolam | 41 | 14 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 41 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 41 | 27 |
| Bupropion Hcl | Bupropion Hcl | 40 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 40 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | suppressed |
| Lactulose | Lactulose | 39 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 18 |
| Insulin Aspart Flexpen | Insulin Aspart | 38 | 24 |
| Tradjenta | Linagliptin | 38 | suppressed |
| Celecoxib | Celecoxib | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 17 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 37 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 36 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | 17 |
| Bicalutamide | Bicalutamide | 32 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 32 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 31 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 31 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 20 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 28 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 28 | 14 |
| Lacosamide | Lacosamide | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 22 |
| Topiramate | Topiramate | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Digoxin | Digoxin | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 19 |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Levetiracetam Er | Levetiracetam | 24 | suppressed |
| Nystatin | Nystatin | 24 | 12 |
| Scopolamine | Scopolamine | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 15 |
| Olanzapine Odt | Olanzapine | 23 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Creon | Lipase/Protease/Amylase | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | 13 |
| Divalproex Sodium Er | Divalproex Sodium | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 15 |
| Ondansetron Odt | Ondansetron | 22 | 16 |
| Albuterol Sulfate | Albuterol Sulfate | 21 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 21 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | 13 |
| Glucagon Emergency Kit | Glucagon | 20 | 13 |
| Ozempic | Semaglutide | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 16 |
| Haloperidol | Haloperidol | 16 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | 12 |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | 13 |
| Trulicity | Dulaglutide | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Mirabegron Er | Mirabegron | 13 | suppressed |
| Rufinamide | Rufinamide | 13 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | 11 |
| Brilinta | Ticagrelor | 11 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Mesalamine Dr | Mesalamine | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $207.75 · 10 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | APRETUDE, CAPLYTA, Cologuard Collection Kit, Fibroscan, INSPIRE, OPSUMIT, The Cologuard Plus Collection Kit, UPTRAVI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error